| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8669244 | The Journal of Heart and Lung Transplantation | 2018 | 8 Pages |
Abstract
In the current era, use of enhanced chemotherapy regimens for isolated advanced AL cardiac amyloidosis was associated with outcomes comparable to non-amyloid cardiomyopathy. We conclude that heart transplantation in highly selected patients with isolated non-systemic advanced cardiac amyloidosis may be a feasible approach.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Arnt V. MD, Michael M. MD, Patrick MD, Stefan O. MD, Lutz MD, Andreas O. MD, Benjamin MSc, Matthias MD, Bastian MD, Arjang MD, Ute MD, Hugo A. MD, Philip W.J. MD,